Litcius/Paper detail

mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2

Tamarand L. Darling, Baoling Ying, Bradley Whitener, Laura A. VanBlargan, Traci L. Bricker, Chieh-Yu Liang, Astha Joshi, Gayan Bamunuarachchi, Kuljeet Seehra, Aaron J. Schmitz, Peter Halfmann, Yoshihiro Kawaoka, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond, Adrianus C. M. Boon

2022Med17 citationsDOIOpen Access PDF

Topics & Concepts

VirologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)BiologyMedicineInternal medicineDiseaseInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesRespiratory viral infections research
mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2 | Litcius